| View |
|
DRP-7108-01
|
Sitagliptin (as phosphate monohydrate)
|
Lupigliptin
|
100 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase-4 Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
01 December 2021
|
20 April 2026
|
| View |
|
DRP-9555-01
|
Loratadine
|
None
|
10 mg
|
Tablet
|
Antihistamine
|
Centurion Laboratories Pvt. Ltd.
|
India
|
-
|
01 December 2021
|
27 July 2026
|
| View |
|
DRP-9806-02
|
Dexamethasone phosphate (as sodium)
|
Dextar-S
|
4 mg/mL (8 mg/ 2 mL)
|
Solution for injection (I.M./I.V.)
|
Corticosteroid
|
Makcur Laboratories Limited
|
India
|
-
|
01 December 2021
|
09 June 2026
|
| View |
|
DRP-10266-01
|
Temisartan
|
Mezartel-80
|
80 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Macter International Ltd.
|
Pakistan
|
-
|
01 December 2021
|
01 December 2025
|
| View |
|
DRP-2170-04
|
Azithromycin (as dihydrate)
|
Azithrobet
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Zim Laboratories Limited
|
India
|
-
|
20 November 2021
|
14 May 2025
|
| View |
|
DRP-4474-13
|
Ceftriaxone (as sodium)
|
Neozefrax
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporins)
|
Brawn Laboratories Ltd
|
India
|
Renewal
|
12 October 2022
|
13 June 2028
|
| View |
|
DRP-5964-01
|
Losartan Potassium + Hydrochlorothiazide
|
Jansar 100 Plus
|
100 mg/25 mg
|
Film-Coated Tablet
|
Angiotensin-II-Receptor Blocker/Diuretic
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
27 January 2023
|
27 February 2028
|
| View |
|
DRP-6162-02
|
Fenofibrate
|
Fenobet
|
200 mg
|
Capsule
|
Lipid Modifying Agents (Fibrates)
|
Cooper Pharma Limited
|
India
|
Renewal
|
27 January 2023
|
10 February 2028
|
| View |
|
DRP-2632-01
|
Ascorbic acid + Zinc
|
C2ZINC
|
500 mg (equivalent to 562.4 mg Sodium ascorbate) / 10mg (equivalent to 27.5 mg Zinc sulfate monohydrate)
|
Capsule
|
-
|
La Croesus Pharma, Inc
|
Philippines
|
-
|
26 November 2021
|
12 November 2026
|
| View |
|
DRP-5529-01
|
Tamsulosin Hydrochloride
|
Unbranded
|
200 mcg
|
Enteric-Coated Tablet
|
Alpha-Adrenoreceptor Antagonist
|
Unicure Remedies Pvt. Ltd.
|
India
|
Renewal
|
25 March 2024
|
23 September 2029
|
| View |
|
DRP-8584-10
|
Pantoprazole (as sodium sesquihydrate) + Domperidone
|
Pantoel
|
40 mg/ 30 mg
|
Modified-Release Capsule
|
Proton Pump Inhibitor/ Gastrokinetic
|
Theon Pharmaceuticals Limited
|
India
|
-
|
25 November 2021
|
18 December 2024
|
| View |
|
DRP-8810-01
|
Thiamine Mononitrate (Vitamin B1) + Pyridoxine Hydrochloride (Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
None
|
100 mg/5 mg/50 mcg
|
Tablet
|
Vitamins
|
Am-Europharma Corporation
|
Philippines
|
-
|
03 December 2021
|
06 April 2025
|
| View |
|
DRP-9441-01
|
Sitagliptin (as phosphate monohydrate)
|
Lupigliptin
|
50 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase-4 Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
21 April 2022
|
17 April 2027
|
| View |
|
DRP-10270-01
|
Telmisartan
|
Mezartel-20
|
20 mg
|
Film-coated tablet
|
Angiotensin II Receptor Blocker
|
Macter International Ltd
|
Pakistan
|
-
|
25 November 2021
|
01 December 2025
|
| View |
|
HRP-417-01
|
Tretinoin + Hydroquinone
|
K Beauty
|
10 mg/2 g per 100 mL (0.01% / 2%)
|
Topical Solution
|
Exfoliant / Anti-Acne / Depigmenting
|
Refinette Cosmetic Manufacturing Corporation
|
Philippines
|
-
|
05 November 2021
|
15 March 2026
|
| View |
|
DRP-3456-01
|
Azithromycin (as Dihydrate)
|
Jiaamycin
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
10 January 2022
|
22 December 2026
|
| View |
|
DRP-6164-02
|
Cefpodoxime (as proxetil)
|
Ceffdo-200
|
200 mg
|
Film-Coated Tablet
|
Antibacterial
|
Brawn Laboratories Limited
|
India
|
Renewal
|
15 June 2024
|
22 May 2030
|
| View |
|
DRP-7376-04
|
Amlodipine (as Besilate)
|
Amlus-10
|
10 mg
|
Tablet
|
Calcium Channel Blocker (Dihydropyridine Derivative)
|
Hiral Labs Limited
|
India
|
-
|
05 November 2021
|
26 February 2026
|
| View |
|
HRP-475
|
Ascorbic Acid
|
Ascophil
|
500 mg
|
Tablet
|
Vitamin
|
Jiangxi Xierkangtai Pharmaceutical Co., Ltd
|
China
|
Renewal
|
10 June 2024
|
29 October 2029
|
| View |
|
DRP-6950-01
|
Cefoperazone (as Sodium) + Sulbactam (as Sodium)
|
Zulb
|
1 g / 500 mg
|
Powder for Injection (IM/IV)
|
-
|
BioRX Pharma Labs LLP
|
India
|
-
|
03 November 2021
|
14 December 2026
|